Vivos Therapeutics (VVOS) Leases (2021 - 2025)
Historic Leases for Vivos Therapeutics (VVOS) over the last 5 years, with Q3 2025 value amounting to $3.4 million.
- Vivos Therapeutics' Leases rose 19964.57% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 19964.57%. This contributed to the annual value of $1.0 million for FY2024, which is 2548.74% down from last year.
- Vivos Therapeutics' Leases amounted to $3.4 million in Q3 2025, which was up 19964.57% from $3.2 million recorded in Q2 2025.
- In the past 5 years, Vivos Therapeutics' Leases ranged from a high of $3.4 million in Q3 2025 and a low of $516000.0 during Q4 2021
- Over the past 5 years, Vivos Therapeutics' median Leases value was $1.5 million (recorded in 2022), while the average stood at $1.6 million.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 22848.84% in 2022, then tumbled by 3110.9% in 2023.
- Over the past 5 years, Vivos Therapeutics' Leases (Quarter) stood at $516000.0 in 2021, then soared by 228.49% to $1.7 million in 2022, then decreased by 18.29% to $1.4 million in 2023, then fell by 25.49% to $1.0 million in 2024, then surged by 227.81% to $3.4 million in 2025.
- Its Leases was $3.4 million in Q3 2025, compared to $3.2 million in Q2 2025 and $951000.0 in Q1 2025.